当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Baclofen
HUMAN COMPOUNDED DRUG
71300-6638
Nubratori Inc.
2024-2
BACLOFEN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 g
71300-6638-4
071011 CICLOPIROX 3% / ITRACONAZOLE 5% / UREA 20%
HUMAN COMPOUNDED DRUG
72934-3357
SKNV
2024-2
UREA; CICLOPIROX OLAMINE; ITRACONAZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 g/100 mL; 3 g/100 mL; 5 g/100 mL
72934-3357-2
141014 HYDROQUINONE 4% / TRETINOIN 0.025% / TRIAMCINOLONE ACETONIDE 0.025%
HUMAN COMPOUNDED DRUG
72934-6374
SKNV
2024-2
TRIAMCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.025 g/100 mL; 4 g/100 mL; .025 g/100 mL
72934-6374-2
141074 HYDROCORTISONE 0.5% / HYDROQUINONE 6%
HUMAN COMPOUNDED DRUG
72934-6394
SKNV
2024-2
HYDROCORTISONE; HYDROQUINONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 g/100 mL; 6 g/100 mL
72934-6394-2
031085 FINASTERIDE 0.1% / MINOXIDIL 7% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-4353
SKNV
2024-2
FINASTERIDE; TRETINOIN; MINOXIDIL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.1 g/100 mL; .025 g/100 mL; 7 g/100 mL
72934-4353-8
141025 HYDROCORTISONE 0.5% / HYDROQUINONE 8% / TRETINOIN 0.05%
HUMAN COMPOUNDED DRUG
72934-6378
SKNV
2024-2
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 g/100 mL; 8 g/100 mL; .05 g/100 mL
72934-6378-2
141059 HYDROCORTISONE 0.5% / HYDROQUINONE 8% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-6385
SKNV
2024-2
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.5 g/100 mL; 8 g/100 mL; .025 g/100 mL
72934-6385-2
221012 IBUPROFEN 2% / SALICYLIC ACID 17%
HUMAN COMPOUNDED DRUG
72934-1435
SKNV
2024-1
IBUPROFEN; SALICYLIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 17 g/100 mL
72934-1435-2
011019 CLINDAMYCIN 1% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-3303
SKNV
2024-1
NIACINAMIDE; CLINDAMYCIN PHOSPHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 g/100 mL; 1 g/100 mL
72934-3303-3
011014 CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-2302
SKNV
2024-1
CLINDAMYCIN PHOSPHATE; TRETINOIN; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/100 mL; .025 g/100 mL; 4 g/100 mL
72934-2302-2
011043 NIACINAMIDE 4% / SULFACETAMIDE SODIUM MONOHYDRATE 15%
HUMAN COMPOUNDED DRUG
72934-3310
SKNV
2024-1
SULFACETAMIDE SODIUM; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 g/100 mL; 4 g/100 mL
72934-3310-2
Fentanyl/Ropivacaine
HUMAN COMPOUNDED DRUG
72055-014
Baycare Integrated Service Center, LLC /dba BayCare Central Pharmacy
2024-2
ROPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/100 mL; 200 ug/100 mL
72055-014-01
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
72055-013
Baycare Integrated Service Center, LLC /dba BayCare Central Pharmacy
2024-2
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/5 mL
72055-013-01
Oxytocin
HUMAN COMPOUNDED DRUG
71266-5103
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [iU]/500 mL
71266-5103-1
Vancomycin Bag
HUMAN COMPOUNDED DRUG
71266-5085
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1500 mg/250 mL
71266-5085-1
Vancomycin Bag
HUMAN COMPOUNDED DRUG
71266-5083
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1250 mg/250 mL
71266-5083-1
Vancomycin Bag
HUMAN COMPOUNDED DRUG
71266-5082
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1000 mg/250 mL
71266-5082-1
Semaglutide
HUMAN COMPOUNDED DRUG
71266-6100
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-2
SEMAGLUTIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
71266-6100-1
Estradiol
HUMAN COMPOUNDED DRUG
70168-5008
BSO LLC
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
70168-5008-1
351037 CICLOPIROX 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%
HUMAN COMPOUNDED DRUG
72934-7426
SKNV
2024-2
SALICYLIC ACID; CICLOPIROX OLAMINE; CLOBETASOL PROPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 g/100 mL; .77 g/100 mL; .05 g/100 mL
72934-7426-6
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3